Cite
HARVARD Citation
Wang, Y. et al. (2020). Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule‐1 (MAdCAM‐1), in Patients With Ulcerative Colitis or Crohn's Disease. Journal of clinical pharmacology. pp. 903-914. [Online].